Hospital
Henan Cancer Hospital河南省肿瘤医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
National key clinical specialties 7 at evidence level A or B
-
Published research 13 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 37 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
National key clinical specialties
| Specialty | Batch | Evidence | Source |
|---|---|---|---|
| TCM Oncology 中医肿瘤专业 | Not published | Level B | https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html |
| Nursing 护理专业 | Not published | Level B | https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html |
| General Surgery 普外科 | 2022 | Level B | https://anti-cancer.com.cn/Mobile/Journal/ArticleIndex/2171 |
| Laboratory Medicine 检验科 | Not published | Level B | https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html |
| Pathology 病理科 | Not published | Level B | https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html |
| Medical Oncology 肿瘤科 | Not published | Level B | https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html |
| Thoracic Surgery 胸外科 | 2011 | Level B | https://www.anti-cancer.com.cn/Html/News/Articles/13202.html |
7 specialty rows, each carrying its own evidence level.
Each row carries its own evidence level and its own source. Level definitions are on the methodology page.
Values written in Chinese are quoted as published by the source.
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 河南省肿瘤医院
- English name
- Henan Cancer Hospital
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
National key clinical specialty
- General Surgery (level B) https://anti-cancer.com.cn/Mobile/Journal/ArticleIndex/2171
Published research
- MAL2-driven lipid droplets as Trojan horses: Subverting immune surveillance to promote colorectal cancer liver metastasis. Cancer letters, 2026
- Author Correction: Machine learning model-guided selective use of temporary diverting ileostomy in rectal cancer surgery: a randomized controlled trial. Nature communications, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Breast cancer
Published research
- In silico studies, synthesis, and biological evaluation of novel imidazopyridine-based CYP4Z1 inhibitors targeting breast cancer stem cells. European journal of medicinal chemistry, 2026
- Spatial habitat radiomics predicts tertiary lymphoid structure status and identifies an IDO1(+) migratory dendritic cell axis in breast cancer. Journal for immunotherapy of cancer, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Lung cancer
National key clinical specialty
- Thoracic Surgery (level B) https://www.anti-cancer.com.cn/Html/News/Articles/13202.html
Published research
- DONSON links tumor-cell survival to MIF-associated macrophage remodeling in small cell lung cancer. Apoptosis : an international journal on programmed cell death, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Liver cancer
Published research
- [TACE-HAIC versus HAIC combined with targeted immunotherapy for unresectable hepatocellular carcinoma: a propensity score-matched retrospective controlled study]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026
- Diagnostic performance of the 2024 LI-RADS nonradiation treatment response algorithm in hepatocellular carcinoma treated with locoregional plus immune-targeted therapy. European journal of radiology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Stomach cancer
Published research
- Complete and durable remission in a patient with brain metastasis from gastric cancer treated with SRS followed by RC48 plus camrelizumab after progression on chemo-immunotherapy: a case report and literature review. Frontiers in immunology, 2026
- The SLC35B2/YAP1 axis contributes to the inhibitory effects of CLIC-2-overexpressing cancer-associated fibroblast-derived exosomes on gastric cancer progression. Cellular signalling, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Esophageal cancer
National key clinical specialty
- Thoracic Surgery (level B) https://www.anti-cancer.com.cn/Html/News/Articles/13202.html
Published research
- Liquid Biopsy and Nonendoscopic Biomarkers for Precision Early Detection of Esophageal Cancer: Evidence, Risk Stratification and Translational Challenges. Journal of Cancer, 2026
- Comparison and validation of two proposed modifications to the current lymph node classification for esophageal squamous cell carcinoma. Surgical oncology, 2026
1 more published study
PubMed indexes 3 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Pancreatic cancer
Fudan specialty reputation ranking 2023
- Medical Oncology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- General Surgery (level B) https://anti-cancer.com.cn/Mobile/Journal/ArticleIndex/2171
- Medical Oncology (level B) https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html
-
Bone and soft tissue sarcoma
Fudan specialty reputation ranking 2023
- Medical Oncology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Medical Oncology (level B) https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html
Other hospitals in Zhengzhou
Source & evidence
- Source URL
- https://www.fdygs.com/news2023-1.aspx
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24